Compare WCN & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WCN | TEVA |
|---|---|---|
| Founded | 1997 | 1901 |
| Country | Canada | Israel |
| Employees | N/A | N/A |
| Industry | Power Generation | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.9B | 40.5B |
| IPO Year | 2005 | 1996 |
| Metric | WCN | TEVA |
|---|---|---|
| Price | $164.81 | $41.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 28 | 13 |
| Target Price | ★ $197.12 | $47.58 |
| AVG Volume (30 Days) | 1.4M | ★ 5.4M |
| Earning Date | 10-21-2026 | 11-03-2026 |
| Dividend Yield | ★ 0.89% | N/A |
| EPS Growth | 74.48 | ★ 183.45 |
| EPS | ★ 2.02 | N/A |
| Revenue | ★ $9,466,915,000.00 | N/A |
| Revenue This Year | $6.15 | N/A |
| Revenue Next Year | $5.67 | $3.39 |
| P/E Ratio | $77.52 | ★ N/A |
| Revenue Growth | ★ 6.14 | N/A |
| 52 Week Low | $146.89 | $18.83 |
| 52 Week High | $179.74 | $42.02 |
| Indicator | WCN | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 68.31 | 63.86 |
| Support Level | $163.48 | $38.28 |
| Resistance Level | $172.07 | N/A |
| Average True Range (ATR) | 3.18 | 1.02 |
| MACD | 1.20 | 0.07 |
| Stochastic Oscillator | 99.14 | 78.25 |
Waste Connections is a North American waste management company focused on integrated waste collection services. The firm primarily focuses on residential, commercial, municipal, and industrial waste collection, with a secondary market focus on rural areas. With 113 landfills and 222 transfer stations as of 2024, it is the third-largest waste management company by revenue. Revenue is split among six operating segments: Western, Southern, Eastern, Central, Canada, and Midsouth.
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.